EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Early analgesic response to interventional pain procedures in hospitalized patients with cancer-related pain: clinical predictors and exploratory survival analysis

Joon Hee Lee, Jiwon Yoon, Byunghun Min, Minhye Chang, Francis Sahngun Nahm, Pyung Bok Lee, Eun Joo Choi

Supportive Care in Cancer · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Purpose Interventional pain procedures (IPPs) are increasingly considered earlier for cancer-related pain, yet the clinical predictors and prognostic relevance of early analgesic response to IPP remain unclear. We aimed to identify predictors of early response and evaluate its implication for 1-year survival outcomes. Methods This retrospective cohort study included 349 hospitalized cancer patients undergoing their first inpatient IPP. Early analgesic response was defined by changes in daily mean NRS scores and morphine equivalent daily dose (MEDD) over a 48-h peri-procedural period. Based on these criteria, patients were categorized into overall responders and non-responders. Independent predictors of this early response were identified using multivariable logistic regression, and 1-year survival outcomes were evaluated using Kaplan–Meier analysis with the log-rank test and multivariable Cox proportional hazards regression. Results Among 349 patients, overall responders (25.5%) were independently associated with higher baseline NRS (odds ratio [OR], 2.13; 95% confidence interval [CI], 1.63–2.83; P < 0.001) and lower baseline MEDD (OR, 0.95 per 10-mg increase; 95% CI, 0.92–0.98; P < 0.001). In multivariable Cox regression, early analgesic response was not independently associated with 1-year mortality (adjusted hazard ratio for non-responders vs. overall responders, 1.26; 95% CI, 0.90–1.77; P = 0.176), although univariable analysis indicated a significant survival advantage (log-rank test, P = 0.037). Conclusion Higher pain intensity and lower opioid use predict a favorable early analgesic response to IPP, suggesting an optimal therapeutic window for cancer-related pain intervention. Early analgesic response to IPP may serve as an exploratory prognostic indicator in patients with cancer-related pain.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Joon Hee Lee, Jiwon Yoon, Byunghun Min, Minhye Chang, Francis Sahngun Nahm, Pyung Bok Lee, Eun Joo Choi
Quelle
Supportive Care in Cancer
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0941-4355, 1433-7339
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Joon Hee Lee, Jiwon Yoon, Byunghun Min, Minhye Chang, Francis Sahngun Nahm, Pyung Bok Lee, Eun Joo Choi (2026). Early analgesic response to interventional pain procedures in hospitalized patients with cancer-related pain: clinical predictors and exploratory survival analysis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-11004-2
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1